Literature DB >> 2644446

Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.

J E LoSardo1, L A Cupelli, M K Short, J W Berman, J Lenz.   

Abstract

Transcriptional activities of the long terminal repeats (LTRs) of various murine leukemia viruses were tested in the cytotoxic T-cell lines CTLL-1 and CTLL-2. In contrast to T-lymphoma cells, in which the LTRs of T-lymphomagenic virus SL3-3 and Moloney murine leukemia virus are more active than those of other viruses, transcriptional activity in these mature, interleukin-2-dependent cells is not correlated with the specificity of viral leukemogenicity. Several approaches were used to investigate the molecular basis for LTR activity differences in lymphoma cells and mature cytotoxic T cells. Deletion analysis of the Moloney virus LTR showed that the direct repeats associated with enhancer activity have, at most, a slight effect on expression in CTLL-1 cells, whereas they stimulate expression six- to eightfold in T-lymphoma cells. This suggests that the mature T-cell line lacks one or more factors present in T-lymphoma cells that function to augment transcription from the Moloney murine leukemia virus LTR. We also used recombinant viral LTRs to investigate the role of the enhancer core element of SL3-3 in CTLL-1 and CTLL-2 cells. A one-base-pair difference between the core sequences of SL3-3 and nonleukemogenic Akv virus, which is important for SL3-3 activity in T-lymphoma cells, had no effect in these cells. The inability to distinguish the single-base-pair difference in expression assays was correlated with the absence of binding of a cellular factor, S-CBF, to the SL3-3 enhancer core in extracts of CTLL-1 and CTLL-2 nuclei. These studies may have implications for identification of the target cells for viral leukemogenesis, as well as for tracing of changes in the transcriptional machinery during T-lymphocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644446      PMCID: PMC247802     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

2.  Retention of lymphocyte characteristics by myelomas and theta + -lymphomas: sensitivity to cortisol and phytohemagglutinin.

Authors:  P Ralph
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

3.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

4.  The role of MuLV receptors on T-lymphoma cells in lymphoma cell proliferation.

Authors:  M S McGrath; E Pillemer; D Kooistra; I L Weissman
Journal:  Contemp Top Immunobiol       Date:  1980

Review 5.  Enhancer elements.

Authors:  G Khoury; P Gruss
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

6.  Wrinkled DNA.

Authors:  S Arnott; R Chandrasekaran; L C Puigjaner; J K Walker; I H Hall; D L Birdsall; R L Ratliff
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  Multiple point mutations affecting the simian virus 40 enhancer.

Authors:  H Weiher; M König; P Gruss
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Molecular cloning of viral DNA from leukemogenic Gross passage A murine leukemia virus and nucleotide sequence of its long terminal repeat.

Authors:  R Villemur; E Rassart; L DesGroseillers; P Jolicoeur
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

10.  Monoclonal cytolytic T-cell lines.

Authors:  P E Baker; S Gillis; K A Smith
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  20 in total

1.  Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.

Authors:  J C Tupper; H Chen; E F Hays; G C Bristol; F K Yoshimura
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.

Authors:  H L Morrison; H Y Dai; F S Pedersen; J Lenz
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences.

Authors:  S Lovmand; N O Kjeldgaard; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  DNA-binding proteins that interact with the long terminal repeat of radiation leukemia virus.

Authors:  I Gorska-Flipot; P Jolicoeur
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Characterization of enhancer elements and their mutations in the long terminal repeat of feline endogenous RD-114 proviruses.

Authors:  A K Ghosh; P Roy-Burman
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses.

Authors:  K Paludan; H Y Dai; M Duch; P Jørgensen; N O Kjeldgaard; F S Pedersen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy.

Authors:  J G Julias; D Hash; V K Pathak
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.

Authors:  S C Lawrenz-Smith; A C Massey; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Origins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.

Authors:  A C Massey; S C Lawrenz-Smith; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines.

Authors:  M Plumb; R Fulton; L Breimer; M Stewart; K Willison; J C Neil
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.